Dr. Amy M Weise D.O.
Oncologist | Medical Oncology
1414 W Fair Ave Suite 332 Marquette MI, 49855About
Dr. Amy Weise is an oncologist practicing in Marquette, MI. Dr. Weise specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Weise manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Northeast Ohio Medical University 1994
Michigan State University College of Osteopathic Medicine 1996
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of MedicineClinical Trials
- The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
- A Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
- Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
- A Safety Study of SGN-LIV1A in Breast Cancer Patients
- A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
- A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Treatments
- Melanoma
- Skin Cancer
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Lymphoma
- Pain
Dr. Amy M Weise D.O.'s Practice location
Dr. Amy M Weise D.O.'s reviews
Write ReviewPatient Experience with Dr. Weise
Recommended Articles
- Oncoplastic Surgery Success Story at Tufts Medical Center
While there are thousands of difficulties that surround breast cancer, one of the largest for many women is losing their breasts in surgery. While it is a necessary evil due to the cancer, it can be very difficult on confidence and self-image. If they wish to reconstruct their breasts, there are...
- Some Women May Benefit from Delaying Breast Reconstruction After Mastectomy, New Research Suggests
Mastectomy can be a daunting, but incredibly effective treatment for women who are diagnosed with breast cancer. In the surgery, all breast tissue is removed from the infected breast in an effort to treat or remove cancerous cells, but for women who undergo this surgery, the end result leaves much...
- Why is Ovarian Cancer Trickier to Contract Compared to Other Cancers?
Ovaries are part of the reproductive organs of a woman. They are almond-sized organs that are located deep within the abdominal cavity. Ovarian cancer is a cancer that forms in the ovaries. Due to the location of the ovaries, it is difficult to diagnose ovarian cancer in the early stages due to the...
- Cyclist Battles Back from Lymphoma to Make Professional Debut
In October of 2015, 16-year-old Zack Gilmore felt a lump behind his ear after finishing a cycling training session. He went to the doctor to find out what it was and, three days later, he received the dreadful news: a non-Hodgkin’s lymphoma diagnosis. Gilmore began chemotherapy right away at the...
- New Treatment for Difficult To Treat Type of Ovarian Cancer
Ovarian clear cell carcinoma is one of the most difficult forms of ovarian cancers to treat, but there may be a new approach for therapy. The potential new form of therapy was discovered by Wistar scientists and discussed in detail in the online medical journal, Nature Cell Biology.Between 5 and 10...
- NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma
The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...